- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01931345
The SPOT Project : Motivational Interviewing in Conjunction With Rapid HIV Testing
The SPOT Project: Effect of Counseling Based on Motivational Interviewing Offered in Conjunction With Rapid HIV Testing on the Occurrence of Unprotected Anal Sex and Its Determinants Among Men Who Have Sex With Men (MSM) in Montreal
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In Canada, the prevalence and incidence of HIV remain high among men who have sex with men (MSM). Moreover, epidemiological data show that a significant proportion of transmission can be attributed people who are unaware of their HIV status. To address these challenges, HIV testing has the potential to be a major prevention strategy. Indeed, the combination of testing and treatment (test & treat) is now seen to be one of the most promising strategies in terms of its potential contribution to the eradication of HIV.
To maximize testing among MSM, it has been recommended that services be diversified by offering HIV testing in close proximity to areas where people most at risk for HIV reside and socialize. Rapid HIV testing can also help reduce barriers in access to testing by reaching those most at risk more effectively in non-traditional venues. In addition, testing offers an excellent opportunity and psycho-affective context within which to provide individualized counseling in order to explore preventive practices and testing routines.
Since July 2009, the SPOT project has combined a number of strategies (testing services in close proximity to a residential area; free, anonymous, and rapid HIV testing; individualized preventive counseling) in an original way at an innovative community site located in the heart of Montreal's Gay Village. In the first phase of the study, standard counseling (SC) based on Quebec guidelines for rapid HIV testing was used. During the second, counseling based on a motivational interviewing approach (MIC) was developed and has been provided to participants since May 2011.
Taking advantage of the existing infrastructure, the objective of the current phase of the study is to assess the short and medium term impact of MIC and its cognitive determinants in comparison to SC. The occurrence of at-risk anal intercourse (unprotected anal sex with an HIV-positive partner or partner of unknown HIV status) will be measured at baseline and followed over six months. Four cognitive determinants of at-risk anal sex will also be measured: the importance that participants accord to taking the necessary steps to protect themselves from HIV, perceived personal efficacy in achieving this, intention to do so, and the extent to which participants have planned to do so.
To achieve this objective, a 24 months randomized trial will be implemented SPOT's community site. Participants who present for HIV testing will be randomized between the two conditions, MIC and SC, alternated at a ratio of 1/1 (experimental condition: MIC offered by a community worker; control condition: SC offered by a nurse). Outcome measures will be collected by means of questionnaires. Four measurement times are planned. A baseline questionnaire will be administered prior to pre-test counseling at the start of the initial visit. Outcome measures will be assessed at baseline (T0), and in follow-up questionnaires administered after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2) and at 6 months after the initial visit (T3). Target enrolment at T0 is 900, for a final sample of 508 participants at T3, representing 254 participants per group (MIC, SC). Mechanisms will be put in place to ensure the integrity of both MIC and SC interventions as well as to retain participants and involve community members in the research process.
In the wake of the recommendations of the Federal Initiative to Address HIV/AIDS in Canada, this study will provide data on the effectiveness of different forms of preventive counseling tailored for use in conjunction with rapid HIV testing. If MIC proves to be effective, the training and clinical supervision offered to intervention staff as well as the tools and quality control procedures developed during the implementation of this approach to counseling will be made available in other settings where testing is offered. Important lessons may also be learned with regards to the organization of services and the benefits and challenges associated with the implementation of this type of HIV prevention infrastructure. Ultimately, this study will contribute to efforts to more effectively combat the HIV epidemic amongst MSM in Canada and reduce the direct and indirect costs associated with HIV in these communities.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H2L 3K9
- SPOT, 1223-A rue Amherst
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male
- 18 years of age or older
- Resident of Quebec
- Able to understand French or English
- Unprotected anal sex with a man on at least one occasion in the last 3 years
- HIV-negative or HIV status unknown
Exclusion Criteria:
- Symptoms of fever (over 38°C), headache, muscular pain, fatigue, and/or swollen lymp
- Previously tested at SPOT
- Enrolled as a participant in the IPERGAY study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Motivational Interviewing Counseling
Counseling developed by the research team based on a motivational interviewing approach
|
Counseling developed by the research team based on a motivational interviewing approach
|
|
Active Comparator: Standard counseling
Counseling based on Quebec guidelines for rapid HIV testing
|
Counseling based on Quebec guidelines for rapid HIV testing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline occurrence of at-risk anal intercourse at 6 months
Time Frame: Prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3)
|
Occurrence of at-risk anal intercourse will be assessed prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3).
|
Prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline importance that participants accord to taking the necessary steps to protect themselves from HIV at 6 months
Time Frame: Prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3)
|
Importance that participants accord to taking the necessary steps to protect themselves from HIV will be assessed prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3).
|
Prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3)
|
|
Change from baseline perceived personal efficacy in protecting themselves from HIV at 6 months
Time Frame: Prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3)
|
Perceived personal efficacy in protecting themselves from HIV will be assessed prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3)
|
Prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3)
|
|
Change from baseline intention to protect themselves from HIV at 6 months
Time Frame: Prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3)
|
Intention to protect themselves from HIV will be assessed prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3)
|
Prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3)
|
|
Change from baseline extent to which participants have planned to protect themselves from HIV at 6 months
Time Frame: Prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3)
|
Extent to which participants have planned to protect themselves from HIV will be assessed prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3)
|
Prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Joanne Otis, Ph.D., Université du Québec à Montréal
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SPOT
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on High-risk Sex
-
The First Affiliated Hospital of Anhui Medical...CompletedThe Effects of Individualized Oxygen Dynamic on Prognosis of Patients With High-risk Cardiac SurgeryCardiac Disease | High Risk SexChina
-
Amsterdam UMC, location VUmcPulsecath BV.RecruitingHigh-risk PCI | Coronary Artery Disease Risk HighNetherlands
-
Magenta Medical Ltd.RecruitingHigh-Risk Percutaneous Coronary Intervention (High-risk PCI)United States
-
Boston Children's HospitalWithdrawnDepression | Substance-related Disorders | High-risk SexUnited States
-
Alnylam PharmaceuticalsHoffmann-La RocheRecruitingHypertension | High Cardiovascular Risk | High Risk Cardiovascular DiseaseUnited States, Belgium, Germany, Portugal, Spain, Italy, Taiwan, Bulgaria, Czechia, Poland, Canada, Austria, Japan, Greece, United Kingdom, Australia, New Zealand, South Korea, Brazil, Chile, Denmark, France, Hungary, Netherlands, Romania, Slovak... and more
-
Suzhou Hengruihongyuan Medical Technology Co. LTDRecruitingHigh-Risk Percutaneous Coronary Intervention (High-risk PCI) | Left Ventricular Assist DevicesChina
-
Shenzhen Core Medical Technology CO.,LTD.Shenzhen Core Medical Technology CO.,LTD.Active, not recruitingHigh-Risk Percutaneous Coronary Intervention (High-risk PCI) | Left Ventricular Assist DevicesChina
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
New York City Health and Hospitals CorporationNew York State Department of HealthCompletedHigh-risk, High-cost Medicaid Services UsersUnited States
-
University of OxfordWellcome Trust; Jazz PharmaceuticalsNot yet recruitingClinical High Risk for Psychosis | Clinical High Risk for Psychosis (CHR) | Clinical High Risk for Developing PsychosisUnited Kingdom, Italy, Greece, Finland, Germany, Netherlands, Austria, Canada, Spain, Switzerland
Clinical Trials on Motivational Interviewing Counseling
-
Johns Hopkins UniversityZanvyl and Isabelle Krieger FundCompleted
-
University of NebraskaCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseCompleted
-
University of Cape TownVU University of AmsterdamUnknown
-
Kaiser PermanenteCompletedDiabetes | Physical Activity | PreDiabetes
-
Ohio State UniversityCompletedObesity | OverweightUnited States
-
VA National Center for Rehabilitative Auditory...US Department of Veterans AffairsTerminated
-
Indiana UniversityCompleted
-
University of WashingtonNational Institute of Dental and Craniofacial Research (NIDCR)UnknownPreventive Health ServicesUnited States
-
Brown UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular DiseasesUnited States